The trademark application NUCLEIX was filed by Nucleix Limited, a corporation established under the laws of the State of Israel (the "Applicant"). Application under examination.
The application was filed in English (French was selected as the second language).
Goods And Services
The mark was filed in class 1 with following description of goods:
Biochemical reagents for non-medical purposes
Diagnostic preparations and reagents for scientific or research use
Chemical and diagnostic preparations for clinical laboratory research or medical laboratory research use.
The mark was filed in class 5 with following description of goods:
Diagnostic test kits for medical and clinical use comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease
Medical diagnostic assay kits comprised of reagents for use in identifying and measuring changes associated with cancer, precancerous conditions or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease
Medical diagnostic kits comprised of medical diagnostic reagents and assays for use in the field of cancer detection or detection of chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease
Diagnostic reagents for medical purposes.
The mark was filed in class 10 with Apparatus for medical diagnostic testing in the field of cancer or chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease.
The mark was filed in class 42 with following description of goods:
Pharmaceutical research and development
Consulting services in the fields of biotechnology and pharmaceutical research and development
Custom design and development of chemical reagents and biochemical assays.
The mark was filed in class 44 with following description of goods:
Consulting services in the field of health
Consulting services in the field of diagnostic medical testing
Medical analysis for the diagnosis of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease and prognosis of expected progression of the diseases
Medical testing for diagnostic or treatment purposes in the fields of the detection and treatment of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease
Providing cancer screening services
Providing screening services for chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease
Providing a website featuring information in the fields of the diagnosis and treatment of cancer and chronic obstructive pulmonary disease (COPD) or autoimmune disease or neurological disease.